Insulin is a salt hormone. It tells your kidneys to hold on to sodium — and where salt goes, water follows, and where water goes, pressure follows. Why so much high blood pressure is quietly a metabolic problem.
High blood pressure is the most-treated chronic condition in the Western world. Nearly everyone knows someone on a tablet for it. And almost nobody has been told what, for a great many of them, is actually driving it.
The story you'll hear is about salt and stress and stiff pipes — and those play a part. But underneath a large share of high blood pressure sits the same fire this series keeps returning to: high insulin. Because insulin, quite apart from its job with blood sugar, is also a salt hormone. It tells your kidneys to hold on to sodium. And where sodium goes, water follows.
Blood pressure is the force of blood pushing against your artery walls. It rises and falls all day — normal. "Hypertension" means it stays high, and that genuinely matters: sustained high pressure wears out arteries, heart, kidneys and brain over years. This is not a number to shrug at. It earns its nickname, the silent killer.
But notice what the diagnosis actually is: a reading. Like a high cholesterol number, it measures something — it doesn't, by itself, explain why. And for most people, the honest medical position is remarkable when you hear it plainly:
"Essential hypertension" is the name given to high blood pressure with no identified cause — and it's the vast majority of cases. But "unknown cause" and "no cause" are not the same thing. Follow the fire, and a great deal of that "unknown" stops being mysterious — because one of the body's most powerful salt-retaining signals is running high in exactly these people, and almost no one is measuring it.
Here's the mechanism, in plain steps — settled physiology, not speculation. Insulin tells your kidneys to keep salt.[1] Salt holds on to water. More water means more volume, and in a closed loop of vessels, more volume means more pressure — like a hosepipe stiffening when you open the tap wider.
Notice what the drugs do and don't do. Each one brings the number down — real, useful work. But drag the flood back up with a drug on, and the pressure climbs again: the drug bails water out of the boat while the fire keeps the tap running. Only turning down the flood itself lowers the volume at its source.
Your body has a dedicated hormone whose main job is to tell the kidneys how much salt to keep: aldosterone. (If you read Cholesterol, you met it — one of the steroid hormones built from cholesterol.) It's run by a system called RAAS — essentially the body's thermostat for salt, water and pressure.
Here's the powerful insight. Insulin and aldosterone are both salt-retention signals, acting on the same kidneys — two hands pulling on the same rope, the one that holds sodium in the body. Normally aldosterone does the job alone. But when insulin is chronically high, it adds a second, constant pull that was never meant to be there.
The salt gets the blame. But for many, it was never the salt — it was the instruction to keep it.
Look at the main drugs with the mechanism in mind. Each is a genuinely useful tool for bringing a dangerous number down — and each works downstream of the fire, managing the pressure while the insulin-driven salt retention rolls on.
Notice the shape. Diuretics and RAAS drugs are, in effect, working to undo the salt retention high insulin is busy creating. The drug bails water out of the boat; the fire keeps the tap running. It's real, useful bailing — and it never turns off the tap.
If a large part of the pressure is insulin telling the kidneys to hoard salt, then addressing the cause means turning down the insulin — the same move as every chapter of the fire. And blood pressure is the condition where you can often see it happen fastest.
When you cut the refined carbohydrate that spikes insulin, two things happen within days, not months:
This is why people often watch their blood pressure fall within the first week or two of cutting carbohydrate — faster than almost any other change in the body. Not magic; just the volume coming down as retained salt and water leave.
Some people feel rough the first week — the so-called "keto flu": headache, fatigue, light-headedness, cramps. Here's what almost nobody explains: a lot of it is just the flip side of the mechanism above. You've dumped a load of sodium and water — and now you're mildly salt-depleted. The fix is counter-intuitive and simple: add salt back. A little extra on food, or a pinch in water, resolves most of it. The very sodium-shedding that lowers your pressure is what leaves you briefly short — so a modest amount of added salt during the transition isn't the enemy; it's the remedy.
Now the honesty the rest of the chapter earns. Blood pressure is not all insulin, and this piece would be worthless if it pretended otherwise.
High blood pressure is genuinely dangerous, and the drugs that lower it do real, worthwhile work — no one should stop them on the strength of an article. But for a great many people the pressure is driven, in large part, by high insulin telling the kidneys to hold salt: the fire, acting through the same rope as aldosterone. The drugs bail water out of the boat while the fire keeps the tap running — and nobody measures the insulin driving it.
So the real conversation with your doctor isn't only "is my blood pressure controlled?" It's "what is driving it — and could we measure the fire, not just the pressure?" A fasting insulin test costs little and would tell you whether the tap is even running. That's the question that turns a lifetime of bailing into a chance of turning off the tap.
Ask your body. Ask what's driving the number. Then you can see the fire for yourself.
Blood pressure is one more flame of the one fire. Back to the whole picture: The Invisible Fire.
[1] DeFronzo RA (1981). The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 21(3):165-171. PMID 7028550. Read →
[2] Horita S et al. (2011). Insulin resistance, obesity, hypertension, and renal sodium transport. Int J Hypertens 2011:391762. PMID 21629870. Read →
[3] Ashtary-Larky D et al. (2024). Impact of very-low-carbohydrate ketogenic diets on cardiovascular risk factors in type 2 diabetes — a GRADE-assessed systematic review and meta-analysis. PMID 39030553. (29 trials; systolic BP −2.85 mmHg, diastolic −1.40 mmHg vs control, alongside falls in fasting insulin, HOMA-IR and triglycerides.) Read →